CHRISTINA GREENE: Open Payments
NPI 1689202426 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 10 payments from 9 companies in 2025. Trend: 2023 $1,229 · 2024 $377 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 1 | $144 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Janssen Biotech, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $28 |
| ABBVIE INC. | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
Products named: SOFDRA, COSENTYX, TREMFYA, CIBINQO, SKYRIZI, ILUMYA, OTEZLA, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
